GlassScriptPhysician profile
Cassandra Cox
NPI 1215749858
$417.17
in general payments reported to CMS, 2019-2025
10 companies · $417 in 2025
The $417 reported for 2025 was more than what a typical Primary Care provider received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $306 · Education: $111.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $305.68 |
| Education | $111.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $155.25 | 2025 | Austedo Xr |
| Abbvie INC. | $46.60 | 2025 | |
| Alpha Cognition USA, INC. | $45.85 | 2025 | Zunveyl |
| Dexcom, INC. | $34.57 | 2025 | Dexcom G6 Transmitter |
| Otsuka America Pharmaceutical, INC. | $30.69 | 2025 | Rexulti |
| Protega Pharmaceutials INC | $27.92 | 2025 | Roxybond |
| Ardelyx, INC. | $24.61 | 2025 | Ibsrela |
| Aimmune Therapeutics, INC. | $22.55 | 2025 | Zenpep |
| Organogenesis INC. | $16.13 | 2025 | Puraply Wound Matrix |
| Axsome Therapeutics, INC. | $13.00 | 2025 | Auvelity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassandra Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.